SCHEMBL17811489

SCHEMBL17811489

C=C(c1ccc(SC)cc1)c1cccc(C(=C)c2ccc(SCCCC)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
MAPT P10636 1/20 0.40
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
PLK1 P53350 4/20 0.37
AR P10275 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
XDH P47989 1/20 0.34
MAP1LC3B Q9GZQ8 1/20 0.33
MAP1LC3A Q9H492 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17811535 0.94 MAOA (0.45) MAOAMAOBMAPTTHRATHRB
SCHEMBL18902814 0.88 MAOA (0.40) MAOAMAOBMAPTTHRATHRB
SCHEMBL17811484 0.85 SLC6A4 (0.36) MAOAMAPTPLK1SMN1; SMN2TAS1R3
SCHEMBL17811486 0.84 MAOA (0.40) MAOAMAOBMAPTTHRATHRB
SCHEMBL17811483 0.83 MEN1 (0.41) MAPTPLK1SMN1; SMN2NPC1RAB9A
SCHEMBL17811490 0.82 MAOA (0.40) MAOAMAOBMAPTTHRATHRB
SCHEMBL17815538 0.79 SLC6A4 (0.40) MAOAMAPTTAS1R3TAS1R1NPC1
SCHEMBL17815472 0.77 MAOA (0.43) MAOAMAOBMAPTTHRATHRB
SCHEMBL2283730 0.76 C1S (0.41) PLK1SMN1; SMN2KMT2ACYP3A4CYP2C19
SCHEMBL17815473 0.75 MAOA (0.44) MAOAMAOBMAPTTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005869-B2 Polymerisation initiators TRINSEO EUROPE GMBH (CH) 2018-06-26 US disclosed
US-20160159956-A1 Polymerisation Initiators TRINSEO EUROPE GMBH (CH) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005869-B2 Polymerisation initiators ELOVL5, ELOVL3, ELOVL1 MAOA 1229/4885MAOB 2182/4885MAPT 2465/4885
US-20160159956-A1 Polymerisation Initiators ELOVL5, ELOVL3, ELOVL1 MAOA 1229/4885MAOB 2182/4885MAPT 2465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.